Retatrutide
Triple incretin receptor agonist
An experimental peptide that acts on three hormone receptors. Researchers studied it in phase 2 trials involving weight and blood sugar.
Plain-English peptide research. Affiliate links are disclosed.Peptides explained in plain English, from published research. Veritide sells nothing; some links to a third-party UK laboratory supplier earn us a commission. Research and educational reference only — not medical advice.
Also cited in the literature as GRF (1-29)
A short copy of the body's own growth-hormone-releasing hormone. It was once sold as a medicine for testing growth hormone in children.
Regulatory status: Not licensed as a medicine in the United Kingdom. It holds no MHRA marketing authorisation, has no approved indication, and is not approved for human or animal use.

Hormone & signalling research
Research stage: Historic licensed diagnostic use overseas; no current authorisation
The research pathway — not every compound has reached human trials. Illustrations are simplified, not study results.
Sermorelin is a laboratory-made copy of the first 29 amino acids of growth-hormone-releasing hormone, the signal the brain uses to tell the pituitary gland to release growth hormone.
Studies found that sermorelin acted on the same receptor as the natural hormone, prompting the pituitary gland to release stored growth hormone rather than adding hormone from outside.
Human studies used it mainly as a test of whether the pituitary gland could release growth hormone, and it was once sold for exactly that purpose.
Small studies in older adults reported short-term rises in growth hormone and IGF-1 readings, but not improvements in health, strength or body composition.
The record is small and dated, and no current UK licence exists.
For laboratory research use only. Not a medicine and not for human or animal use.
Veritide does not sell or supply anything. This links to a third-party UK laboratory supplier; we may earn a commission if you buy through it, at no extra cost to you. Materials are sold for laboratory research use only and are not licensed medicines.
Triple incretin receptor agonist
An experimental peptide that acts on three hormone receptors. Researchers studied it in phase 2 trials involving weight and blood sugar.
Dual GLP-1 / glucagon receptor agonist
An experimental peptide based on a natural gut hormone. Researchers studied it mainly in phase 2 and phase 3 trials in China.
Synthetic pentadecapeptide
A laboratory-made peptide made of 15 amino acids. Almost all published research involved cells or rodents rather than people.